Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Richard B. Wilder"'
Autor:
George Yang, Tobin J. Strom, Richard B. Wilder, Kushagra Shrinath, Eric A. Mellon, Daniel C. Fernandez, Matthew C. Biagioli
Publikováno v:
International Brazilian Journal of Urology, Vol 41, Iss 3, Pp 435-441 (2015)
ABSTRACTPurposeTo evaluate dosimetric coverage of the prostate, normal tissue sparing, and acute toxicity with HDR brachytherapy for large prostate volumes.Materials and MethodsOne hundred and two prostate cancer patients with prostate volumes >50 mL
Externí odkaz:
https://doaj.org/article/5c11ce4e5f324365aac814ff889f7f7f
Autor:
Jessika A. Contreras, Richard B. Wilder, Eric A. Mellon, Tobin J. Strom, Daniel C. Fernandez, Matthew C. Biagioli
Publikováno v:
International Brazilian Journal of Urology, Vol 41, Iss 1, Pp 40-45 (2015)
Purpose There is little information in the literature on health-related quality of life (HRQOL) changes due to high-dose-rate (HDR) brachytherapy monotherapy for prostate cancer. Materials and Methods We conducted a prospective study of HRQOL changes
Externí odkaz:
https://doaj.org/article/d8691ef3b42542629427bbeec1e6094f
Autor:
Kamran A. Ahmed, Richard B. Wilder
Publikováno v:
International Brazilian Journal of Urology, Vol 41, Iss 1, Pp 78-85 (2015)
Objectives To evaluate post-orchiectomy utilization of radiation therapy (RT) versus other management approaches in stage IIA and IIB testicular seminoma patients. Materials and Methods Two hundred and forty-one patients with stage IIA and IIB testic
Externí odkaz:
https://doaj.org/article/45e50a2768594e08bcd4069f4c74f45a
Autor:
Tobin J. Strom, Sean Z. Hutchinson, Kushagra Shrinath, Alex A. Cruz, Nicholas B. Figura, Kevin Nethers, Matthew C. Biagioli, Daniel C. Fernandez, Randy V. Heysek, Richard B. Wilder
Publikováno v:
International Brazilian Journal of Urology, Vol 40, Iss 4, Pp 474-483 (2014)
Purpose To assess outcomes with external beam radiation therapy (EBRT) and a low-dose-rate (LDR) brachytherapy boost without or with androgen deprivation therapy (ADT) for prostate cancer. Materials and Methods From January 2001 through August 2011,
Externí odkaz:
https://doaj.org/article/9cafd3c17a2a4b4c815284ed68d15ae8
Autor:
Jessica M. Freilich, Philippe E. Spiess, Matthew C. Biagioli, Daniel C. Fernandez, Ellen J. Shi, Dylan C. Hunt, Shilpa Gupta, Richard B. Wilder
Publikováno v:
International Brazilian Journal of Urology, Vol 40, Iss 2, Pp 190-197 (2014)
Purpose To evaluate Lipiodol as a liquid, radio-opaque fiducial marker for image-guided radiation therapy (IGRT) for bladder cancer.Materials and Methods Between 2011 and 2012, 5 clinical T2a-T3b N0 M0 stage II-III bladder cancer patients were treate
Externí odkaz:
https://doaj.org/article/d05cbe736c3142a59024ab60214de318
Publikováno v:
International Brazilian Journal of Urology, Vol 43, Iss 4, Pp 628-637
ABSTRACT Purpose To evaluate quality of life (QoL) after post-prostatectomy intensity modulated radiation therapy (IMRT) in the “adjuvant” setting starting within 4 months of radical prostatectomy for adverse features; and “salvage” setting f
Externí odkaz:
https://doaj.org/article/64d719ed0f054c5a8832cbd2e0927561
Autor:
Kosj Yamoah, Peter A.S. Johnstone, Julio M. Pow-Sang, Richard B. Wilder, Austin J. Sim, Michael A. Poch, Casey Liveringhouse
Publikováno v:
Rep Pract Oncol Radiother
BACKGROUND: The aim of the study was to investigate the safety of combining preoperative stereotactic body radiotherapy (SBRT) with robotic radical prostatectomy (RP) for high risk prostate cancer (HRCaP). Many patients with HRCaP will require adjuva
Autor:
Tobin Strom, Kevin Nethers, Alex Cruz, Daniel C. Fernandez, Randy V. Heysek, Richard B. Wilder, Eric A. Mellon, Dylan Hunt, Nicholas Figura, Amarjit S. Saini, Kushagra Shrinath
Publikováno v:
Brachytherapy. 14:818-825
Purpose To compare urinary, bowel, and sexual health-related quality-of-life (HRQOL) changes due to high-dose-rate (HDR) brachytherapy, low-dose-rate (LDR) brachytherapy, or intensity-modulated radiation therapy (IMRT) monotherapy for prostate cancer
Autor:
Clayton Lau, Daniel W. Lin, Eric Jonasch, Neeraj Agarwal, Brian Shuch, Sam S. Chang, Mary A. Dwyer, Robert J. Motzer, Roberto Pili, Jenny J. Kim, Clair J. Beard, Steven L. Hancock, Thomas Olencki, Sam B. Bhayani, Joel Sheinfeld, Shilpa Gupta, Charles J. Ryan, Kanishka Sircar, Timothy M. Kuzel, Brad Somer, Richard B. Wilder, Graeme B. Bolger, Edward N. Rampersaud, Brian A. Costello, Bruce G. Redman, Elizabeth R. Plimack, Ithaar Derweesh, Elaine T. Lam, Ellis G. Levine, Toni K. Choueiri, M. Dror Michaelson, Rashmi Kumar
Publikováno v:
Memorial Sloan Kettering Cancer Center
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These NCCN Guidelines Insights highlight the recent updates/changes in these g
Autor:
Tobin Strom, Alex Cruz, Randy V. Heysek, Arash O. Naghavi, Jongphil Kim, Binglin Yue, Kushagra Shrinath, Nicholas B Figura, Richard B. Wilder, Matthew C. Biagioli, Kevin Nethers, Daniel C. Fernandez
Publikováno v:
International Journal of Clinical Oncology. 20:598-604
The objectives are to determine predictors of a prostate-specific antigen (PSA) bounce, whether a PSA bounce after radiotherapy for prostate cancer is associated with biochemical disease-free survival (bDFS), and the time course to a PSA bounce versu